These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 2903446

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 25. c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.
    Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA.
    Cancer Res; 1992 Mar 01; 52(5):1107-13. PubMed ID: 1737370
    [Abstract] [Full Text] [Related]

  • 26. Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients.
    Tokatli F, Altaner S, Uzal C, Ture M, Kocak Z, Uygun K, Bilgi S.
    Exp Oncol; 2005 Jun 01; 27(2):145-9. PubMed ID: 15995634
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N, Ragab HM, El Maksoud NA, Shaalan M.
    Cancer Biomark; 2010 Jun 01; 6(2):63-72. PubMed ID: 20571232
    [Abstract] [Full Text] [Related]

  • 30. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF, Maguire HC, Greene MI, Weiner DB, LiVolsi VA.
    Mod Pathol; 1990 Jul 01; 3(4):449-54. PubMed ID: 2170971
    [Abstract] [Full Text] [Related]

  • 31. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.
    Bevilacqua G, Sobel ME, Liotta LA, Steeg PS.
    Cancer Res; 1989 Sep 15; 49(18):5185-90. PubMed ID: 2475243
    [Abstract] [Full Text] [Related]

  • 32. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y, Booser DJ, Sneige N.
    Cancer; 2005 May 01; 103(9):1763-9. PubMed ID: 15786420
    [Abstract] [Full Text] [Related]

  • 33. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.
    Ross JS, Fletcher JA.
    Stem Cells; 1998 May 01; 16(6):413-28. PubMed ID: 9831867
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2007 May 01; 27(4A):1969-74. PubMed ID: 17649807
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.
    Press MF, Hung G, Godolphin W, Slamon DJ.
    Cancer Res; 1994 May 15; 54(10):2771-7. PubMed ID: 7909495
    [Abstract] [Full Text] [Related]

  • 39. Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters.
    Lundy J, Schuss A, Stanick D, McCormack ES, Kramer S, Sorvillo JM.
    Am J Pathol; 1991 Jun 15; 138(6):1527-34. PubMed ID: 1711294
    [Abstract] [Full Text] [Related]

  • 40. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb 15; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.